Open AccessP392: PHARMACOLOGICAL INHIBITION OF SYK CONFERS ANTI‐PROLIFERATIVE AND NOVEL ANTI‐TUMOR IMMUNE RESPONSES IN AML
Author(s) -
Carvajal L. A.,
Robinson B.,
Kosaka Y.,
Jacob T.,
Lee J.,
Hood T.,
Baker K.,
Kaempf A.,
Amara S. N.A.,
Pucilowska J.,
Lind E.,
Tog C.,
Tyner J.,
Kumar P.,
Vu T.,
DiMartino J.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844456.64162.e9
Subject(s) - syk , bone marrow , cancer research , myeloid leukemia , medicine , ex vivo , immune system , pharmacology , immunology , biology , in vivo , tyrosine kinase , receptor , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom